Which donor or graft source should you choose for the strongest GVL? Is there really any difference

被引:6
|
作者
Weisdorf, Daniel [1 ]
机构
[1] Univ Minnesota, Adult Blood & Marrow Transplant Program, Minneapolis, MN 55455 USA
关键词
bone marrow; graft source; GVL; graft-versus-leukemia; haploidentical; HCT; hematopoietic cell transplantation; HLA-matched donors; peripheral blood; relapse; UCB; umbilical cord blood; UMBILICAL-CORD BLOOD; HEMATOPOIETIC-CELL TRANSPLANTATION; UNRELATED DONOR; BONE-MARROW; ACUTE-LEUKEMIA; POSTTRANSPLANTATION CYCLOPHOSPHAMIDE; STEM-CELLS; OUTCOMES; ADULTS; RECIPIENTS;
D O I
10.1016/j.beha.2013.10.010
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Patients undergoing allogeneic hematopoietic cell transplantation (HCT) face relapse of their malignancy as the most frequent cause of treatment failure. It has been postulated that the allogeneic neoplastic potency of different donor or graft sources may differ and in some situations, a particular graft source might be preferred. Data on this supposition has been reviewed here to consider HLA-matched siblings, HLA-matched or partially matched unrelated donors (URD), unrelated umbilical cord blood (UCB), and haploidentical as well as blood or marrow grafts. (C) 2013 Elsevier Ltd. All rights reserved.
引用
收藏
页码:293 / 296
页数:4
相关论文
共 28 条
  • [21] Does it really matter which drug you choose? An examination of the influence of type of drug on type of risky sexual behavior
    Ritchwood, Tiarney D.
    DeCoster, Jamie
    Metzger, Isha W.
    Bolland, John M.
    Danielson, Carla K.
    ADDICTIVE BEHAVIORS, 2016, 60 : 97 - 102
  • [22] Which should you choose for post operative atrial fibrillation, carvedilol or metoprolol? A systemic review and meta-analysis
    Abouzid, Mohamad Riad
    Vyas, Ankit
    Eldahtoury, Samar
    Anwar, Junaid
    Naccour, Shereen
    Elshafei, Shorouk
    Memon, Areeba
    Subramaniam, Venkat
    Bennett, William
    Morin, Daniel P.
    Lavie, Carl J.
    Nwaukwa, Chima
    CURRENT PROBLEMS IN CARDIOLOGY, 2024, 49 (02)
  • [23] Surgical correction of moderate myopia: Which method should you choose? II. PRK and LASIK are the treatments of choice.
    Steinert, RF
    Bafna, S
    SURVEY OF OPHTHALMOLOGY, 1998, 43 (02) : 157 - 179
  • [24] Does it really make any difference which contrast imaging modality we use in conjunction with stress Echocardiography on the accuracy of the test?
    Dolan, MS
    St Vrain, J
    Sklenar, J
    Sheriff, D
    Maniet, A
    Labovitz, AJ
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (06) : 432A - 433A
  • [25] Surgical correction of moderate myopia: Which method should you choose? I. Radial keratotomy will always have a place.
    Rowsey, JJ
    Morley, WA
    SURVEY OF OPHTHALMOLOGY, 1998, 43 (02) : 147 - 156
  • [26] Options for aortic valve replacement in children and young adults: "Okay, doctor, but which one do you think I should choose?''
    Al-Radi, Osman O.
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2016, 151 (01): : 153 - 154
  • [27] The new face of SCADA systems - Differences between SCADA packages are increasingly hard to spot. So which one should you choose?
    Butts, B
    CONTROL AND INSTRUMENTATION, 1995, 27 (12): : 23 - 24
  • [28] Is there any difference in the recovery from delayed graft function in recipients of acute renal failure donor kidneys between mycophenolate mofetil and sirolimus based immunosuppressive therapy?
    Dunn, M
    Toh, SJI
    Ranganna, K
    Ahmed, Z
    Heifets, M
    Kumar, MA
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2006, 47 (04) : A28 - A28